• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 RNA 编辑的宫颈癌患者预后风险模型的构建与评估。

Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.

机构信息

Department of Biostatistics, School of Public Health, Nanjing Medical University 101 Longmian Avenue, Nanjing, P.R. China.

Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

出版信息

Medicine (Baltimore). 2024 May 10;103(19):e38116. doi: 10.1097/MD.0000000000038116.

DOI:10.1097/MD.0000000000038116
PMID:38728474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11081546/
Abstract

RNA editing, as an epigenetic mechanism, exhibits a strong correlation with the occurrence and development of cancers. Nevertheless, few studies have been conducted to investigate the impact of RNA editing on cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC). In order to study the connection between RNA editing and CESC patients' prognoses, we obtained CESC-related information from The Cancer Genome Atlas (TCGA) database and randomly allocated the patients into the training group or testing group. An RNA editing-based risk model for CESC patients was established by Cox regression analysis and least absolute shrinkage and selection operator (LASSO). According to the median score generated by this RNA editing-based risk model, patients were categorized into subgroups with high and low risks. We further constructed the nomogram by risk scores and clinical characteristics and analyzed the impact of RNA editing levels on host gene expression levels and adenosine deaminase acting on RNA. Finally, we also compared the biological functions and pathways of differentially expressed genes (DEGs) between different subgroups by enrichment analysis. In this risk model, we screened out 6 RNA editing sites with significant prognostic value. The constructed nomogram performed well in forecasting patients' prognoses. Furthermore, the level of RNA editing at the prognostic site exhibited a strong correlation with host gene expression. In the high-risk subgroup, we observed multiple biological functions and pathways associated with immune response, cell proliferation, and tumor progression. This study establishes an RNA editing-based risk model that helps forecast patients' prognoses and offers a new understanding of the underlying mechanism of RNA editing in CESC.

摘要

RNA 编辑作为一种表观遗传机制,与癌症的发生和发展密切相关。然而,目前针对 RNA 编辑与宫颈鳞状细胞癌和宫颈内膜腺癌(CESC)之间的关系的研究还很少。为了研究 RNA 编辑与 CESC 患者预后之间的关系,我们从癌症基因组图谱(TCGA)数据库中获取了与 CESC 相关的信息,并将患者随机分配到训练组或测试组。我们通过 Cox 回归分析和最小绝对收缩和选择算子(LASSO)建立了基于 RNA 编辑的 CESC 患者风险模型。根据该 RNA 编辑风险模型生成的中位数评分,我们将患者分为高风险和低风险亚组。我们进一步通过风险评分和临床特征构建了列线图,并分析了 RNA 编辑水平对宿主基因表达水平和腺苷脱氨酶作用于 RNA 的影响。最后,我们还通过富集分析比较了不同亚组间差异表达基因(DEGs)的生物学功能和通路。在该风险模型中,我们筛选出 6 个具有显著预后价值的 RNA 编辑位点。构建的列线图在预测患者预后方面表现良好。此外,预后位点的 RNA 编辑水平与宿主基因表达具有很强的相关性。在高风险亚组中,我们观察到与免疫反应、细胞增殖和肿瘤进展相关的多种生物学功能和通路。本研究建立了基于 RNA 编辑的风险模型,有助于预测患者的预后,并为 RNA 编辑在 CESC 中的潜在机制提供了新的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/f99aa9eef3c6/medi-103-e38116-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/f6cd1b49f74b/medi-103-e38116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/66c44bd737ba/medi-103-e38116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/b8d3ee65fc11/medi-103-e38116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/b8c89405e7cb/medi-103-e38116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/2632c95adee7/medi-103-e38116-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/d9322865f729/medi-103-e38116-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/9ce2e53ae177/medi-103-e38116-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/f99aa9eef3c6/medi-103-e38116-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/f6cd1b49f74b/medi-103-e38116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/66c44bd737ba/medi-103-e38116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/b8d3ee65fc11/medi-103-e38116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/b8c89405e7cb/medi-103-e38116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/2632c95adee7/medi-103-e38116-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/d9322865f729/medi-103-e38116-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/9ce2e53ae177/medi-103-e38116-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5918/11081546/f99aa9eef3c6/medi-103-e38116-g008.jpg

相似文献

1
Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.基于 RNA 编辑的宫颈癌患者预后风险模型的构建与评估。
Medicine (Baltimore). 2024 May 10;103(19):e38116. doi: 10.1097/MD.0000000000038116.
2
Integrating Hypoxia Signatures from scRNA-seq and Bulk Transcriptomes for Prognosis Prediction and Precision Therapy in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.整合来自单细胞RNA测序和批量转录组的缺氧特征用于宫颈鳞状细胞癌和宫颈内膜腺癌的预后预测及精准治疗
Int J Mol Sci. 2025 Feb 6;26(3):1362. doi: 10.3390/ijms26031362.
3
A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.基于多组学的方法研究在宫颈鳞癌和腺癌患者中与坏死性凋亡相关的 mRNA 的预后和免疫影响。
Sci Rep. 2022 Oct 6;12(1):16773. doi: 10.1038/s41598-022-20566-0.
4
Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.基于程序性细胞死亡相关基因的宫颈癌预后生物标志物的鉴定及其免疫特征评估和对药物治疗的反应。
J Gene Med. 2024 Jan;26(1):e3643. doi: 10.1002/jgm.3643. Epub 2023 Dec 4.
5
A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.一种基于免疫相关基因的子宫颈鳞状细胞癌和子宫颈管腺癌预后标志物。
Int Immunopharmacol. 2020 Nov;88:106884. doi: 10.1016/j.intimp.2020.106884. Epub 2020 Aug 11.
6
Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.鉴定与宫颈癌肿瘤免疫微环境相关的坏死性凋亡相关预后基因特征,并进行实验验证。
World J Surg Oncol. 2022 Oct 17;20(1):342. doi: 10.1186/s12957-022-02802-z.
7
Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.识别和验证与凋亡相关的基因特征作为一种新的宫颈癌、宫颈内膜腺癌的预后模型,并揭示免疫浸润。
Medicina (Kaunas). 2023 Feb 13;59(2):358. doi: 10.3390/medicina59020358.
8
A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.基于免疫检查点 HLA-G 驱动的差异表达基因的宫颈癌新型预后风险模型。
Front Immunol. 2022 Jul 18;13:851622. doi: 10.3389/fimmu.2022.851622. eCollection 2022.
9
N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.N6-甲基腺苷相关长链非编码 RNA 作为预测宫颈癌患者预后和免疫反应的潜在生物标志物。
BMC Genom Data. 2022 Jan 18;23(1):8. doi: 10.1186/s12863-022-01024-2.
10
Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.m6A RNA 甲基化调控因子的表达及其在宫颈鳞癌和子宫内膜腺癌中的临床预测价值。
Clin Exp Pharmacol Physiol. 2021 Feb;48(2):270-278. doi: 10.1111/1440-1681.13412. Epub 2020 Oct 21.

本文引用的文献

1
Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics.通过单细胞转录组学分析研究巨噬细胞氧化应激反应和免疫系统在多形性胶质母细胞瘤中的作用。
Front Immunol. 2024 Jan 11;14:1288137. doi: 10.3389/fimmu.2023.1288137. eCollection 2023.
2
RNA Editing in Cancer Progression.癌症进展中的RNA编辑
Cancers (Basel). 2023 Nov 3;15(21):5277. doi: 10.3390/cancers15215277.
3
NOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers.
NOD 样受体信号通路在胃肠道炎症性疾病和癌症中的作用。
Int J Mol Sci. 2023 Sep 25;24(19):14511. doi: 10.3390/ijms241914511.
4
PRR11 in Malignancies: Biological Activities and Targeted Therapies.PRR11 在恶性肿瘤中的作用:生物学活性与靶向治疗。
Biomolecules. 2022 Dec 1;12(12):1800. doi: 10.3390/biom12121800.
5
HPV-Negative Adenocarcinomas of the Uterine Cervix: From Molecular Characterization to Clinical Implications.人乳头瘤病毒阴性的子宫颈腺癌:从分子特征到临床意义。
Int J Mol Sci. 2022 Nov 30;23(23):15022. doi: 10.3390/ijms232315022.
6
A prognostic model for cervical cancer based on ferroptosis-related genes.基于铁死亡相关基因的宫颈癌预后模型。
Front Endocrinol (Lausanne). 2022 Oct 14;13:991178. doi: 10.3389/fendo.2022.991178. eCollection 2022.
7
Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma.辣椒素对子宫内膜癌作用机制的研究及实验验证
Front Pharmacol. 2022 Sep 21;13:953874. doi: 10.3389/fphar.2022.953874. eCollection 2022.
8
A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.基于多组学的方法研究在宫颈鳞癌和腺癌患者中与坏死性凋亡相关的 mRNA 的预后和免疫影响。
Sci Rep. 2022 Oct 6;12(1):16773. doi: 10.1038/s41598-022-20566-0.
9
Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.程序性细胞坏死相关长链非编码 RNA 特征可预测宫颈鳞癌和宫颈内膜腺癌的预后和免疫反应。
Sci Rep. 2022 Sep 29;12(1):16285. doi: 10.1038/s41598-022-20858-5.
10
E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers.E3 连接酶和去泛素化酶调控癌症中的 MAPK 信号通路。
Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188736. doi: 10.1016/j.bbcan.2022.188736. Epub 2022 May 16.